When was Genomes founded?

Genomes was founded in 2013 and raised its 1st funding round 5 years after it was founded.

Where is Genomes located?

Genomes is headquartered in London, United Kingdom. It is registered at 30 Caledonian Road, London, England, N1 9DT.

Which legal entities is Genomes associated with?

Genomes is associated with GENOME LTD.

How many employees does Genomes have?

As of Apr 30, 2026, the latest employee count at Genomes is 9.

Is Genomes a funded company?

Genomes is a funded company, having raised a total of $331K across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 18, 2018.

When was the latest funding round of Genomes?

Genomes' latest funding was a $***** Series A round on Jun 19, 2025, with participation from 0 investor.

Where does Genomes rank among its competitors?

Genomes ranks 4th amongst 9 active competitors, of which 8 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Genomes, which secured an undisclosed amount in Jun, 2025.

Who are the top competitors of Genomes?

Genomes' top competitors include Catalog Technologies, Biomemory and Atlas Data. Among them, Genomes secured the most recent funding round in June, 2025.

Genomes - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Genomes’ is a blockchain application designed to privately, securely store whole genome sequence data for an individual in a manner that allows questions to be asked of the genetic code without exposing the code to others. It uses Ethereum and Rockchain to allow systems to compute a function on private data, without exposing anything about their data besides the result.

Website: genomes.io
Social
Email ID: *****@genomes.io
Registered Address: 30 Caledonian Road, London, England, N1 9DT

Key Metrics

Founded Year

2013

Location

London, United Kingdom

Stage

Series A

Total Funding

$331K in 4 rounds

Latest Funding Round

Series A, Jun 19, 2025, $*****

Investors

Pantera Capital & 5 more

Ranked

4^th among 9 active competitors

Employee Count

9 as on Apr 30, 2026

Similar Companies

Catalog Technologies & 8 more

View Genomes' full profile

Genomes is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
GENOME LTD CIN: 11591997 , United Kingdom, Active	Sep 26, 2018	-	4 (As on Aug 31, 2023)

Genomes has raised a total funding of $331K over 4 rounds. Its first funding round was on Jul 18, 2018. Genomes has 4 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Genomes:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 19, 2025	6174426	Series A	3230022	6447275	6495879	8769973
Jun 12, 2024	6218471	Series A	8128237	8641072	7035464	2364859
Jan 30, 2020	2817042	Seed	9138326	4571180	8782291	6374827

Access funding benchmarks and valuations. Sign up today!

View details of Genomes's funding rounds and investors

The founders of Genomes are Mark Hahnel and Chris Griffiths. Aldo De Pape is the CEO of Genomes.

Here are the details of Genomes' key team members:

Mark Hahnel: Co-Founder of Genomes.
Chris Griffiths: Co-Founder & COO of Genomes.
Aldo De Pape: CEO of Genomes.
Contact Info: 1 email address

View details of Genomes's Founder profiles and Board Members

Genomes' employee count trend

Genomes has 9 employees as of Apr 26. Here is Genomes's employee count trend over the years:

Uncover Genomes' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Genomes include Catalog Technologies, Biomemory and Atlas Data. Here is the list of Top 10 competitors of Genomes, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Catalog Technologies 2016, San Francisco (United States), Series B	Developer of digital information storage system	$54.2M	Horizons Ventures, Airbus Ventures & 28 others	59/100
2nd	Biomemory 2021, Paris (France), Series A	Online platform offering bio-digital data storage solutions	$23.2M	La French Tech, Crédit Mutuel Innovation ... & 15 others	55/100
3rd	Atlas Data 2025, San Francisco (United States), Seed	Provider of cloud-based data storage solutions utilizing DNA as a highly durable, low-cost, and permanent data storage medium	$155M	rsquaredvc.com, Deerfield & 5 others	54/100
4th	Genomes 2013, London (United Kingdom), Series A	Offers blockchain enabled security for sequenced genomes	$331K	Pantera Capital, Consensys Labs & 4 others	52/100
5th	PetaGene 2015, Cambridge (United Kingdom), Acquired	Provider of cloud-based software for genetic data storage, transfer and remote access	$3.2M	Romulus Capital, Entrepreneur First & 5 others	44/100
6th	Genomika 2019, Kaunas (Lithuania), Seed	Developer of a technology for data storage in DNA molecules.	$5.51M	Europa	43/100
7th	Iridia 2016, Carlsbad (United States), Series B	DNA-based data storage solution provider	$36M	LifeSci Venture Partners, Prime Movers Lab ... & 12 others	40/100
8th	Helixworks 2016, Cork (Ireland), Seed	Developer of DNA-based data storage solutions	-	dlab, IKP Knowledge Park & 4 others	33/100
9th	BixBio 2020, Cape Town (South Africa), Seed	Provider of diverse genetic data for developing precision medicine	-	Illumina	22/100
10th	Metis DNA 2021, Deadpooled	Cloud & AI-based data storage management solution	-	-	15/100